Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
A new strategy of CyberKnife treatment system based radiosurgery followed by early use of adjuvant bevacizumab treatment for brain metastasis with extensive cerebral edema
While a Phase I oral safety trial has concluded and some small human case reports show promise, extensive controlled human efficacy data are still in progress
This product is intended strictly for research and laboratory use only
Shipped fast
(2002, August)
US$ 23.84
US$ 25.16
US$ 27.52
US$ 19.99
US$ 21.53
US$ 21.52
US$ 28.65
